Colony Capital (NYSE:CLNY) Lowered to “Hold” at Zacks Investment Research

Zacks Investment Research downgraded shares of Colony Capital (NYSE:CLNY) from a buy rating to a hold rating in a research report sent to investors on Friday morning, Zacks.com reports.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

According to Zacks, “Colony Capital, Inc. is a real estate and investment management firm. The company focused on investing in real estate and real estate-related assets. It serves health care, industrial and hospitality sectors. The company also offers equity and debt management services. Colony Capital Inc., formerly known as Colony NorthStar Inc., is based in Los Angeles, United States. “

Several other equities analysts have also weighed in on CLNY. B. Riley set a $8.00 price target on shares of Colony Capital and gave the company a buy rating in a research report on Monday, September 30th. ValuEngine lowered shares of Colony Capital from a buy rating to a hold rating in a research report on Wednesday, September 4th.

CLNY traded down $0.48 during trading on Friday, hitting $5.00. 4,491,840 shares of the company traded hands, compared to its average volume of 2,597,109. The firm has a market cap of $2.67 billion, a P/E ratio of 8.06 and a beta of 1.43. The stock’s fifty day moving average is $5.64 and its 200 day moving average is $5.23. The company has a quick ratio of 2.13, a current ratio of 2.13 and a debt-to-equity ratio of 0.96. Colony Capital has a one year low of $4.32 and a one year high of $6.28.

Colony Capital (NYSE:CLNY) last posted its quarterly earnings results on Friday, August 9th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.14 by ($0.03). The company had revenue of $573.40 million for the quarter, compared to the consensus estimate of $669.45 million. Colony Capital had a negative net margin of 36.96% and a negative return on equity of 9.60%. Colony Capital’s quarterly revenue was down 16.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.18 EPS. On average, equities research analysts forecast that Colony Capital will post 0.38 EPS for the current fiscal year.

In other Colony Capital news, Director Craig M. Hatkoff acquired 23,000 shares of the company’s stock in a transaction on Wednesday, August 28th. The shares were acquired at an average cost of $4.42 per share, with a total value of $101,660.00. Following the completion of the acquisition, the director now directly owns 61,218 shares in the company, valued at $270,583.56. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Raymond C. Mikulich acquired 20,000 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were acquired at an average cost of $4.56 per share, for a total transaction of $91,200.00. The disclosure for this purchase can be found here. 7.02% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Signaturefd LLC lifted its holdings in Colony Capital by 681.2% during the second quarter. Signaturefd LLC now owns 5,492 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 4,789 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in Colony Capital during the second quarter valued at about $38,000. Usca Ria LLC purchased a new stake in Colony Capital during the second quarter valued at about $54,000. Coastal Investment Advisors Inc. lifted its holdings in Colony Capital by 108.4% during the second quarter. Coastal Investment Advisors Inc. now owns 10,839 shares of the real estate investment trust’s stock valued at $53,000 after purchasing an additional 5,639 shares during the last quarter. Finally, Ballentine Partners LLC purchased a new stake in Colony Capital during the third quarter valued at about $67,000. 79.89% of the stock is currently owned by institutional investors and hedge funds.

About Colony Capital

Colony Capital, Inc (NYSE: CLNY) is a leading global investment management firm with assets under management of $43 billion. The Company manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded real estate investment trusts and registered investment companies.

See Also: What is the NASDAQ?

Get a free copy of the Zacks research report on Colony Capital (CLNY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *

*